Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS
Liquid biopsies allow the non-invasive detection of somatic mutations from tumours. Here, the authors develop and test MSK-ACCESS, an NGS-based clinical assay for identifying low frequency mutations in 129 genes and describe how it benefits patients in the clinic.
Saved in:
Similar Items
-
On the asymptotic behavior of solutions of anisotropic viscoelastic body
by: Yassine Letoufa, et al.
Published: (2021) -
Treatment of recurrent mucosal melanoma of the oral cavity with topical imiquimod and pembrolizumab achieves complete histopathologic remission
by: Richard Carvajal, et al.
Published: (2021) -
Electroencephalography measures of relative power and coherence as reaching skill emerges in infants born preterm
by: Ryota Nishiyori, et al.
Published: (2021) -
Controllable quantum point junction on the surface of an antiferromagnetic topological insulator
by: Nicodemos Varnava, et al.
Published: (2021) -
Treatment of adults with attention-deficit/hyperactivity disorder
by: Dusan Kolar, et al.
Published: (2008)